Very proud of both our Q3 financial results & the strong foundation we have built for growth. From RSV, to UC, to migraines—and more, we expect to launch up to 19 new products or indications in the next 18mos to help address a range of patient needs: on.pfizer.com/Q3 $PFE
Follow
Albert Bourla
@AlbertBourla
Chairman and CEO of . Father. 
Working every day for breakthroughs that change patients’ lives.
Working every day for breakthroughs that change patients’ lives.Albert Bourla’s Tweets
Each year, RSV causes more than 100K child deaths globally. The burden of disease is higher in infants <1yo. Maternal immunization can help, and I’m thrilled to share positive topline data from our trial to develop the first-ever maternal RSV vaccine: on.pfizer.com/3Nobiv
54
19
100
Pfizer scientists are using artificial intelligence (AI) & supercomputing to accelerate the delivery of new vaccines & medicines to patients. So I’m proud to join the AI Council to develop safe and responsible practices that harness the power of AI to improve healthcare.
211
78
67
I am excited to share that ’s Advisory Committee on Immunization Practices has voted to recommend Prevnar-20 to help protect adults previously vaccinated against invasive disease and pneumonia caused by the Streptococcus pneumoniae: on.pfizer.com/3SeWqjD
164
33
71
Incredibly proud to have our colleagues lead the conversation about the power of science and share information on our infectious disease work—including vaccines and anti-infectives—at this year’s : on.pfizer.com/3gbpnzD
157
21
62
Emergency use vaccines have not been approved or licensed by US FDA but have been authorized to prevent COVID-19 in ages 12yrs+ (bivalent) and 6mos+ (monovalent). See Fact Sheets: cvdvaccine-us.com
193
38
30
Show this thread
Early data from our trial evaluating our Omicron BA.4/BA.5-adapted #COVID19 vaccine show increased neutralizing antibodies compared to our Original monovalent vaccine, suggesting it could potentially provide better protection against Omicron BA.4/BA.5: on.pfizer.com/3esniyR
Quote Tweet
I am incredibly proud to share that we have received Emergency Use Authorization from @US_FDA for our Omicron BA.4/BA.5-adapted #COVID19 vaccine for people aged 12 and older: on.pfizer.com/3wIpmIX
Show this thread
675
98
92
Show this thread
Emergency uses of the bivalent vaccine have not been approved or licensed by US FDA but have been authorized to prevent COVID-19 in ages 5yrs+. See Fact Sheets: cvdvaccine-us.com
694
202
116
Show this thread
I’m pleased to share that we have received Emergency Use Authorization from the for our Omicron BA.4/BA.5-adapted #COVID19 vaccine for children aged 5-11. This is an important milestone as we head into the winter months ahead: on.pfizer.com/3MtRKW2
6,304
1,344
715
Show this thread
We’ve come a long way since 2020 in reducing #COVID19 hospitalizations & deaths. Among Medicare beneficiaries, for example, we saw a 39-47% reduction in these outcomes due to vaccinations in 2021. Thanks for believing in the power of science!
435
50
70
I feel honored to have had the opportunity to work with Angela for many years and to see firsthand her passion for helping patients, mentoring women and advancing equity as ’s Chief Commercial Officer and President of our Global Biopharmaceuticals Business.
39
7
24
Show this thread
Congratulations to my friend and colleague Angela Hwang for being named on ’s 2022 Most Powerful Women in Business list:
50
5
46
Show this thread
Excited to welcome our new colleagues from Global Blood Therapeutics. Together we’re working to help close the #healthequity gap for #sicklecell disease patients by advancing potential breakthroughs to address the needs of this underserved community: on.pfizer.com/3M9WfEJ
24
5
36
mCRPC is a form of advanced prostate cancer that impacts 10%-20% of men within a few years of their initial diagnosis. These patients need a solution, and we are working hard to target the disease in new, effective ways.
8
5
30
Show this thread
Today, we took another step forward in our prostate cancer research, sharing positive topline results from our global trial for metastatic castration-resistant prostate cancer (mCRPC), a disease greatly in need of new solutions: on.pfizer.com/3M3jxMy
22
10
62
Show this thread
As flu season approaches, many adults are thinking about ways to help stay healthy. I’m pleased to share that the has approved data on the coadministration of our Prevnar-20 pneumococcal pneumonia vaccine with a flu shot: bit.ly/3rpp0nu
96
28
54
A warm welcome to our talented new colleagues from Biohaven! Together, we’re delivering breakthrough treatment options for patients living with migraine: on.pfizer.com/3C2bJX2
13
4
45
Latinos account for 18% of the US population but make up only 8% of the STEM workforce. Our colleagues Diego Sacristan, Nathaniel Garcia and Mirna Zaragoza discuss how companies can support Latinos’ careers in our latest LinkedIn Live episode: bit.ly/3SqldlE
57
4
24
I have tested positive for COVID. I’m feeling well & symptom free. I’ve not had the new bivalent booster yet, as I was following CDC guidelines to wait 3 months since my previous COVID case which was back in mid-August. While we’ve made great progress, the virus is still with us.
12.8K
4,542
4,249
Pfizer's oral treatment is not approved, but is authorized for emergency use by the FDA to treat mild-to-moderate COVID-19 in high-risk patients 12+, weighing at least 40 kg, with positive results of SARS-CoV-2 viral testing. See safety info: COVID19oralRx.com.
49
25
33
Show this thread
Our agreement with for up to 6 million treatment courses of our #COVID19 oral treatment will help to accelerate access for high-risk patients in need across 132 low-and-middle-income countries: on.pfizer.com/3xIMjfu
54
18
62
Show this thread
I was honored to join our DEI Lead at ’s first-ever #USBusinessSummit, where we—along with 44 other companies—pledged to #HireRefugees over the next 3 years. Welcoming #refugees aligns with Pfizer’s equity value, and we’re excited to help those in need.
40
22
58
Parents are often concerned about meningococcal disease, an uncommon but serious illness that can result in death within 24 hours or in long-term disabilities. Today, we announced positive trial results for our pentavalent meningococcal vaccine candidate: on.pfizer.com/3UaBCvP
121
19
90
The flu causes up to 52,000 US deaths annually, disproportionately impacting racial and ethnic minority groups. To help close the #healthequity gap, we aim to achieve representative diversity in our clinical studies so that we can help support everyone’s healthcare journey.
68
25
46
Show this thread
Currently available flu vaccines typically confer 40%-60% protection. Requiring only the genetic sequence of the #influenza virus, the flexibility of #mRNA technology could potentially allow better matches for seasonal viral strains.
48
19
51
Show this thread
I am incredibly excited to share that we are initiating the first Phase 3 study to evaluate the efficacy of our mRNA-based influenza vaccine candidate: on.pfizer.com/3LahWnT
899
222
294
Show this thread
Excited to see inspiring action through the #CancerMoonshot Initiative. One way or another, cancer touches all our lives, and at , we know we must continue our work to advance breakthroughs to combat these deadly diseases.
129
38
121
Today marks the anniversary of #September11. Through actions small or large, in private or for all to see, each of us can honor the brave souls we lost—and those who rushed to help their fellow citizens that day—by being agents of kindness and good will with our words & actions.
11
10
77
Alopecia areata is an autoimmune disease that causes hair to fall out, affecting around 147 million people globally. We’re working to develop a potential treatment, and I’m happy to share that the FDA and EMA have accepted our submissions: on.pfizer.com/3L8CPQo
29
17
87
She served as a calm and unifying presence for her people throughout some of the world’s most historic events. As this era comes to an end, we send our warmest wishes to His Majesty King Charles III as he begins his reign, one undoubtedly strengthened by his mother’s example.
5
2
40
Show this thread
On behalf of all my Pfizer colleagues, I share our deepest condolences to the people of the United Kingdom, the Commonwealth and the Royal Family on the passing of Her Majesty Queen Elizabeth II.
23
10
126
Show this thread
This week a shipment of patented medicines & vaccines to treat & prevent life-threatening infectious diseases, inflammatory disease & certain cancers arrived in #Rwanda under An Accord for a Healthier World. We are working together to close the #healthequity gap!
Quote Tweet
The Ministry of Health has received eight categories of Pfizer medicines and vaccines for infectious and inflammatory diseases and certain cancers through ‘An Accord for a Healthier World’ signed between the Government of Rwanda and @pfizer.
18
10
44
We need sufficient testing & diagnosis to enable timely & equitable access to COVID treatments. Pfizer is proud to support the Quick Start Consortium through financial commitment & donation of our oral treatment to support scale-up for countries in need. bit.ly/3BgQaCD
18
8
27
With an estimated 410,000 GBS cases worldwide—the largest burden in low- and middle-income countries—we are pursuing a global clinical development strategy with the intent to make a successfully developed vaccine available worldwide as quickly as possible.
11
4
20
Show this thread
About 1 in 4 pregnant women carry Group B Streptococcus bacteria that can be passed to their babies, resulting in 147,000+ infant deaths worldwide each year. Today, granted Breakthrough Therapy Designation for our maternal vaccine candidate: on.pfizer.com/3TMoOvr
17
14
57
Show this thread
Emergency uses of the Bivalent vaccine have not been approved or licensed by US FDA but have been authorized to prevent COVID-19 in ages 12yrs+. See Fact Sheets: cvdvaccine-us.com
23
6
17
Show this thread
Today, the EMA CHMP adopted a positive opinion recommending our Omicron BA.1-adapted #COVID19 vaccine booster, potentially providing Europeans with another solution to address the ongoing challenges of this disease: on.pfizer.com/3R6NT2p
53
9
50
Show this thread
Emergency uses of the Bivalent vaccine have not been approved or licensed by US FDA but have been authorized to prevent COVID-19 in ages 12yrs+. See Fact Sheets: cvdvaccine-us.com
101
65
40
Show this thread
As Americans prepare for the coming fall and winter seasons, this adapted vaccine will be an important tool, as #COVID19 caused by existing and emerging variants could surge.
34
6
41
Show this thread
I am incredibly proud to share that we have received Emergency Use Authorization from for our Omicron BA.4/BA.5-adapted #COVID19 vaccine for people aged 12 and older: on.pfizer.com/3wIpmIX
615
130
199
Show this thread